123 related articles for article (PubMed ID: 15802397)
21. Fracture risk from psychotropic medications: a population-based analysis.
Bolton JM; Metge C; Lix L; Prior H; Sareen J; Leslie WD
J Clin Psychopharmacol; 2008 Aug; 28(4):384-91. PubMed ID: 18626264
[TBL] [Abstract][Full Text] [Related]
22. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study.
Derijks HJ; Heerdink ER; De Koning FH; Janknegt R; Klungel OH; Egberts AC
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):336-44. PubMed ID: 18302302
[TBL] [Abstract][Full Text] [Related]
23. Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Am J Epidemiol; 2005 Mar; 161(5):452-61. PubMed ID: 15718481
[TBL] [Abstract][Full Text] [Related]
24. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
Mills PK; Riordan DG; Cress RD; Goldsmith DF
Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
[TBL] [Abstract][Full Text] [Related]
27. Occupational exposures and ovarian cancer in textile workers.
Wernli KJ; Ray RM; Gao DL; Fitzgibbons ED; Camp JE; Astrakianakis G; Seixas N; Wong EY; Li W; De Roos AJ; Feng Z; Thomas DB; Checkoway H
Epidemiology; 2008 Mar; 19(2):244-50. PubMed ID: 18300714
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
Knight JA; Lesosky M; Blackmore KM; Voigt LF; Holt VL; Bernstein L; Marchbanks PA; Burkman RT; Daling JR; Whittemore AS
Breast Cancer Res Treat; 2008 May; 109(1):157-64. PubMed ID: 17616808
[TBL] [Abstract][Full Text] [Related]
29. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Neuhausen SL; Lynch HT; Rosen B; Ainsworth P; Moller P; Ghadirian P; Isaacs C; Karlan B; Sun P; Narod SA
Gynecol Oncol; 2006 Jan; 100(1):83-8. PubMed ID: 16137751
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.
Spillman MA; Schildkraut JM; Halabi S; Moorman P; Calingaert B; Bentley RC; Marks JR; Murphy S; Berchuck A
Gynecol Oncol; 2005 May; 97(2):543-9. PubMed ID: 15863158
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
33. Body size and risk of epithelial ovarian cancer (United States).
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG; Weiss NS
Cancer Causes Control; 2006 Jun; 17(5):713-20. PubMed ID: 16633919
[TBL] [Abstract][Full Text] [Related]
34. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California.
Mills PK; Riordan DG; Cress RD
Gynecol Oncol; 2004 Oct; 95(1):215-25. PubMed ID: 15385135
[TBL] [Abstract][Full Text] [Related]
35. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
36. Lifetime physical activity and the risk of breast cancer: a case-control study.
Kruk J
Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
[TBL] [Abstract][Full Text] [Related]
37. Gender of offspring and maternal ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
[TBL] [Abstract][Full Text] [Related]
38. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer risk in a large cohort of female antidepressant medication users.
Haque R; Enger SM; Chen W; Petitti DB
Cancer Lett; 2005 Apr; 221(1):61-5. PubMed ID: 15797628
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer risk and use of phenolphthalein-containing laxatives.
Cooper GS; Longnecker MP; Peters RK
Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):35-9. PubMed ID: 14971121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
